Are your patients ready to embrace change?

Article

Happy New Year to you all. I'm sure, by now, the memories of Christmas have faded and the New Year's resolutions have already been broken but I do hope you used the holiday season to recharge your batteries, ready to face whatever 2007 may bring.

We kick off this year with a special focus on the ageing eye - presbyopia. As with all surgical procedures, we highlight the importance of patient communication here. Indeed, some specialists believe that effective communication could yield a practice with a near 100% patient satisfaction record. We have tried our best to cover this diverse and complex area of research, but I'm sure that the best is yet to come. As the year unfolds, I imagine we will be seeing the treatment of presbyopia evolve significantly as the pace of research and development looks set to step up a gear.

Going back to the subject of communication, I was talking with my grandmother over the Christmas break about her progress since she had undergone cataract surgery two months earlier. Now, I admit that English is not her first language and my spoken Greek is far from perfect but, with the help of my trusted translator (my Mother), I asked her how she felt following her surgery. She said that she felt fine but didn't understand why her vision was now blurred with her current prescription of spectacles. When I asked her to remove her spectacles and look at the television, I asked her if she could see better. She confirmed that she could but she insisted on keeping her spectacles on as she was afraid of "developing a headache".

I'd like to thank you for joining us at the beginning of what I'm sure will be another great year.

Fedra Pavlou Editorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.